Panel recommends Merck continue cholesterol drug study
November 13, 2015 at 08:12 AM EST
Nov 13 (Reuters) - Merck & Co said an independent data monitoring committee recommended that the company continue a study of its experimental cholesterol drug, anacetrapib.
